InvestorsHub Logo
Followers 65
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

Re: biopharm post# 320963

Monday, 12/18/2017 8:08:24 AM

Monday, December 18, 2017 8:08:24 AM

Post# of 346716
Bio...a little help...what is this?
"B092 Targeting phosphatidylserine"

What kind of identifier is this B092?

https://www.google.com/search?source=hp&ei=vbw3WrKeMcOvmQHazZLwCg&q=B092+Targeting+phosphatidylserine&oq=B092+Targeting+phosphatidylserine&gs_l=psy-ab.13..35i39k1.1836.1836.0.7324.3.2.0.0.0.0.75.75.1.2.0....0...1c.2.64.psy-ab..1.2.156.6...81.pb5MrFsd6d0

From our resident PS is BS storyteller before it was BS....

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116989765

B092 Targeting phosphatidylserine synergizes with immune checkpoint blockade by inhibiting
multiple immune suppressive mechanisms. Xianming Huang, Jian Gong, Dan Ye, Van Nguyen, Shen Yin,
Carrie Baldwin, Rolf Brekken, Steve King, Jeff Hutchins, Bruce Freimark.



Thanks in Advance and Enjoy the Day!

Hell, I wouldn't mind $20 Billion!!!

PS...could the "sequencing" mentioned be more of the mRNA type?
The scientists at AACR 2015 seemed very excited about "see the RNA" when talking with them. They were also keen on those microsphere thingys. En Vivo Ex Vivo. Better than the mouse pre clinicals. IMHO

wook

Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!!
Research.
Always looking deeper. RIP Dr. Thorpe

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News